A detailed history of Janus Henderson Group PLC transactions in Amgen Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,604,785 shares of AMGN stock, worth $1.55 Billion. This represents 0.79% of its overall portfolio holdings.

Number of Shares
4,604,785
Previous 2,381,133 93.39%
Holding current value
$1.55 Billion
Previous $677 Million 112.52%
% of portfolio
0.79%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $584 Million - $710 Million
2,223,652 Added 93.39%
4,604,785 $1.44 Billion
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $370 Million - $447 Million
1,377,007 Added 137.13%
2,381,133 $677 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $18.7 Million - $21.1 Million
73,147 Added 7.86%
1,004,126 $289 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $66.3 Million - $82.4 Million
-303,402 Reduced 24.58%
930,979 $250 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $18.2 Million - $21.5 Million
84,823 Added 7.38%
1,234,381 $274 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $94.2 Million - $115 Million
417,024 Added 56.93%
1,149,558 $278 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $113 Million - $144 Million
495,198 Added 208.65%
732,534 $192 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $35.7 Million - $40.2 Million
158,921 Added 202.67%
237,336 $53.5 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $70.9 Million - $78.9 Million
-307,278 Reduced 79.67%
78,415 $19.1 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $112 Million - $124 Million
-511,494 Reduced 57.01%
385,693 $93.3 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $102 Million - $117 Million
-514,432 Reduced 36.44%
897,187 $202 Million
Q3 2021

Nov 16, 2021

SELL
$212.27 - $248.7 $5.63 Million - $6.59 Million
-26,516 Reduced 1.84%
1,411,619 $300 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $108 Million - $120 Million
464,461 Added 47.7%
1,438,135 $351 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $43.6 Million - $50.8 Million
-196,611 Reduced 16.8%
973,674 $242 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $52.6 Million - $62.6 Million
242,881 Added 26.19%
1,170,285 $269 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $69.7 Million - $77.5 Million
297,130 Added 47.14%
927,404 $236 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $73.1 Million - $89.7 Million
369,694 Added 141.87%
630,274 $149 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $19.9 Million - $26.4 Million
109,254 Added 72.2%
260,580 $52.8 Million
Q4 2019

Feb 18, 2020

SELL
$189.21 - $243.2 $17.9 Million - $23 Million
-94,740 Reduced 38.5%
151,326 $36.5 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $23.6 Million - $28.2 Million
-135,402 Reduced 35.49%
246,066 $47.6 Million
Q2 2019

Jul 31, 2019

SELL
$166.7 - $195.41 $13.5 Million - $15.8 Million
-81,057 Reduced 17.52%
381,468 $70.3 Million
Q1 2019

Apr 30, 2019

BUY
$180.87 - $203.88 $47.4 Million - $53.4 Million
261,879 Added 130.52%
462,525 $87.9 Million
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $867,024 - $1.01 Million
4,860 Added 2.48%
200,646 $39.1 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $4.55 Million - $5.13 Million
-24,562 Reduced 11.15%
195,786 $40.6 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $54.5 Million - $61.2 Million
-327,940 Reduced 59.81%
220,348 $40.7 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $454 Million - $531 Million
-2,681,509 Reduced 83.02%
548,288 $93.5 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $6.48 Million - $7.24 Million
38,414 Added 1.2%
3,229,797 $562 Million
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $85 Million - $97 Million
-507,968 Reduced 13.73%
3,191,383 $0
Q2 2017

Aug 17, 2017

BUY
N/A
3,699,351
3,699,351 $637 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $180B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.